日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma.

人类 LRH1 在 Ser510 处的异常磷酸化预示着肺鳞状细胞癌预后不良，并促进细胞存活

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14160-6
Mine Hayato, Sugimoto Kotaro, Kobayashi Makoto, Takagi Hironori, Okabe Naoyuki, Muto Satoshi, Kobayashi Yasuyuki, Hashimoto Yuko, Suzuki Hiroyuki, Chiba Hideki
细胞生物学
Human
磷酸化
发表日期：2025
文献求助 收藏

Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period

妊娠全程使用间变性淋巴瘤激酶-酪氨酸激酶抑制剂治疗转移性非小细胞肺癌

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.63592
Kato, Mari; Yamaura, Takumi; Mine, Hayato; Kin, Shogo; Suzuki, Hiroyuki
肺癌
肿瘤
肿瘤免疫
信号转导
淋巴瘤
细胞生物学
发表日期：2024
文献求助 收藏

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers

Wnt/β-catenin信号通路与免疫检查点抑制剂耐药性：从非小细胞肺癌到其他癌症

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines11010190
Muto, Satoshi; Enta, Akio; Maruya, Yoshiyuki; Inomata, Sho; Yamaguchi, Hikaru; Mine, Hayato; Takagi, Hironori; Ozaki, Yuki; Watanabe, Masayuki; Inoue, Takuya; Yamaura, Takumi; Fukuhara, Mitsuro; Okabe, Naoyuki; Matsumura, Yuki; Hasegawa, Takeo; Osugi, Jun; Hoshino, Mika; Higuchi, Mitsunori; Shio, Yutaka; Hamada, Kazuyuki; Suzuki, Hiroyuki
Checkpoint
肺癌
肿瘤
肿瘤免疫
信号转导
Wnt/β-Catenin
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Successful pericardial repair and coverage for late pacemaker lead-related atrial perforation and pneumothorax: a case report

成功行心包修复及覆盖术治疗晚期起搏器导线相关性心房穿孔和气胸：病例报告

期刊:
影响因子:
doi:10.1186/s44215-023-00117-3
Maruya, Yoshiyuki; Yamaura, Takumi; Mine, Hayato; Suzuki, Hiroyuki
发表日期：2023
文献求助 收藏

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report

单次使用帕博利珠单抗治疗后，肺大细胞神经内分泌癌控制长达4年：病例报告

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14615
Watanabe, Masayuki; Matsumura, Yuki; Yamaguchi, Hikaru; Mine, Hayato; Takagi, Hironori; Ozaki, Yuki; Fukuhara, Mitsuro; Muto, Satoshi; Okabe, Naoyuki; Shio, Yutaka; Suzuki, Hiroyuki
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma

CLDN15是恶性胸膜间皮瘤的一种新型诊断标志物

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-91464-0
Watanabe, Masayuki; Higashi, Tomohito; Ozeki, Kana; Higashi, Atsuko Y; Sugimoto, Kotaro; Mine, Hayato; Takagi, Hironori; Ozaki, Yuki; Muto, Satoshi; Okabe, Naoyuki; Matsumura, Yuki; Hasegawa, Takeo; Shio, Yutaka; Suzuki, Hiroyuki; Chiba, Hideki
CLDN1
发表日期：2021
文献求助 收藏

Pulmonary large cell carcinoma, highly positive for PD-L1, shows marked response to pembrolizumab: A case report

肺大细胞癌，PD-L1高度阳性，对帕博利珠单抗治疗反应显著：病例报告

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.13850
Okabe, Naoyuki; Mine, Hayato; Takagi, Hironori; Watanabe, Masayuki; Muto, Satoshi; Matsumura, Yuki; Shio, Yutaka; Suzuki, Hiroyuki
PD-L1
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

A patient with ALK-positive lung adenocarcinoma who survived alectinib-refractory postoperative recurrence for 4 years by switching to ceritinib

一名ALK阳性肺腺癌患者，在接受阿来替尼治疗后出现术后复发，但疗效不佳，后改用色瑞替尼治疗，存活了4年。

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14058
Matsumura, Yuki; Inomata, Sho; Yamaguchi, Hikaru; Mine, Hayato; Takagi, Hironori; Watanabe, Masayuki; Ozaki, Yuki; Yamaura, Takumi; Fukuhara, Mitsuro; Muto, Satoshi; Okabe, Naoyuki; Hasegawa, Takeo; Shio, Yutaka; Suzuki, Hiroyuki
ALK
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Circumferential Spinal Cord Decompression through a Single Posterior Approach with Microendoscopy for Thoracic and Thoracolumbar Ossification of the Posterior Longitudinal Ligament

经单侧后路微创内镜入路行环周脊髓减压术治疗胸腰段后纵韧带骨化

期刊:Asian Spine Journal
影响因子:2.7
doi:10.4184/asj.2015.9.4.605
Seki, Shoji; Mine, Hayato; Kawaguchi, Yoshiharu; Makino, Hiroto; Kimura, Tomoatsu
神经科学
发表日期：2015
文献求助 收藏